Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on Tuesday to protest against the government ...

Notably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...

Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...

San Antonio Spurs coach Gregg Popovich announces he will not return to the sidelines this season after he suffered a mild ...

A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...

Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...

When we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...

The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...

Tenecteplase is administered as a single, 5-second intravenous bolus, providing a faster and simpler option compared to the standard 60-minute infusion of alteplase.

Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...

According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...